Covishield vaccine safe and immunogenic, incident with Chennai volunteer unrelated to vaccine, says Serum Institute

By: |
December 01, 2020 4:16 PM

The Serum institute said that it had followed all the guidelines and regulatory and ethical practice during the manufacturing of vaccine and human trials of the vaccine.

Terming the vaccination of about 70 lakh health workers as the first wave of the first phase of vaccination drive, Dr Paul said that it would be easier to vaccinate health workers as they are already present at the healthcare facilities.Terming the vaccination of about 70 lakh health workers as the first wave of the first phase of vaccination drive, Dr Paul said that it would be easier to vaccinate health workers as they are already present at the healthcare facilities.

World’s largest vaccine manufacturer Serum Institute of India has said that the Coronavirus vaccine candidates developed by the University of Oxford and AstraZeneca is 100 percent safe and the incident which had happened with a Chennai based volunteer was not induced from the vaccine, news agency ANI reported. The Serum institute said that it had followed all the guidelines and regulatory and ethical practice during the manufacturing of vaccine and human trials of the vaccine.

The SII also said that the Principal Investigator and the Ethics Committee monitoring the clinical trials of the vaccine had also found that the medical condition of the trial participant was unrelated to the vaccine. A Chennai based 40 year old man who had enrolled himself as a volunteer during the clinical trials of the vaccine alleged that he had suffered from serious side effects including a neurological breakdown and impairment of several of his cognitive functions due to the vaccine. The volunteer had also sought the compensation worth Rs 5 crore from the vaccine manufacturer and requested the authorities to stop the clinical trials of the vaccine.

In response, the Serum Institute had said that the company sympathised with the condition of the volunteer but it was unrelated to his vaccination by the Coronavirus vaccine. The company had also threatened that it would seek damages for more than Rs 100 crore from the volunteer for labelling such malicious and misconceived allegations on the company. The company had also said that the motive behind the volunteer’s move was to blame his medical problems on the vaccine trial and seek pecuniary advantage from the situation.

The man in his notice sent to the company mentioned that he had been vaccinated on October 1 and after the passage of 10 days, his medical condition suddenly worsened and he started having episodes of vomiting and severe headache afterwards. The notice also alleges that the vaccine had also impaired his cognitive senses and he faced difficulties in recognising his family members and felt disoriented.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1How Punjab farmers utilise kinnow crop waste as bio-enzymes that repel pest, improve soil quality
2Delhi weather update: Minimum temperature settles below season’s average
3South Korea prepares test of 1st domestically made space rocket